Business Context and Reporting Period
Company: NanoViricides, Inc. (NNVC)
Filing Type: Form 8-K (Current Report)
Date of Report: November 6, 2023
Reporting Period: This filing relates to events occurring on October 13, 2023, and the fiscal year ended June 30, 2023.
Key Financial Metrics
This Form 8-K does not contain new financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It serves solely to provide auditor consent for the incorporation of previously reported financial results into a registration statement.
Material Changes
There are no material changes to financial results or disclosures reported in this filing. The document explicitly states that the auditor's consent does not alter any previously reported financial results contained in the Annual Report on Form 10-K for the fiscal year ended June 30, 2023.
Guidance, Outlook, and Management Commentary
Event Description: The Company filed its Form 10-K on October 13, 2023, which included an audit report from EisnerAmper LLP.
Action Taken: The Company is filing Exhibit 23.1, which is the consent of EisnerAmper LLP to the incorporation by reference of the Audit Report into the Company's registration statement on Form S-3 (File No. 333-271706) filed on May 5, 2023.
Outlook: No new guidance or outlook is provided in this filing.
Investor Verification Checklist
- Verify the content of the Form 10-K for the fiscal year ended June 30, 2023, filed on October 13, 2023, for actual financial performance data.
- Review the Form S-3 registration statement (File No. 333-271706) filed on May 5, 2023, to understand the context of the auditor consent.
- Confirm the status of the independent registered public accounting firm, EisnerAmper LLP, regarding the audit of the fiscal 2023 financial statements.